Personalizing the Future of Healthcare
Published July 31, 2019
|
5 min watch
For companies engaged in healthcare monitoring, it will be increasingly important to adopt technology which can monitor patient biometrics continuously. Kevin King, President and Chief Executive Officer, talks to RBC about how iRhythm is redefining the standard for ambulatory cardiac monitoring.
Imagine 2025 is a unique perspective on the forces of change shaping tomorrow’s world, today. Our C-Suite insight videos take you into the minds of the executives whose companies we believe are positioned most effectively for the future.
Kevin M. King
President and Chief Executive Officer, iRhythm
Kevin M. King has served as iRhythm’s President, Chief Executive Officer and a member of the board of directors since July 2012. Mr. King has nearly three decades of experience in the healthcare and IT industries in leadership roles. Previously, he was President, Chief Executive Officer and a Director of Affymetrix, Inc., a publicly traded technology innovator in the field of genetic analysis. Prior to that, he served as President and Chief Executive Officer of Thomson Healthcare, an information services business which focused on a range of healthcare-related businesses. Mr. King was also a senior executive at GE Healthcare, where he led several business units including Magnetic Resonance Imaging and Global Clinical Systems Business. Mr. King began his career at HP’s Medical Products Group, holding leadership roles in Sales, Marketing, R&D, and Business Development. Mr. King has a B.A. in Economics and Biology from the University of Massachusetts and an M.B.A. from New Hampshire College.
HealthcareIRhythmImagine 2025Kevin King
